Beijing Wantai Biological Hits Day High with 4.97% Surge in Stock Price

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. has experienced a notable increase of 4.97% on July 1, 2026, reaching an intraday high of CNY 28.58. This performance stands in contrast to the China Shanghai Composite, which saw a modest gain of 0.44% on the same day. Despite today's uptick, the company has faced significant challenges over the longer term. Over the past year, Beijing Wantai has reported a staggering decline of 52.97%, and its year-to-date performance reflects a decrease of 37.0%. The stock has consistently underperformed against the benchmark, with a three-year decline of 57.6%. Financial metrics reveal a concerning trend, as net sales for the first nine months have contracted by 22.74%, while net profit for the half-year period has plummeted by 202.52%. The company's market capitalization stands at CNY 42,471 million, categorizing it as a large-cap entity within the pharmaceuticals and biotechnology sector. With a high dividend yield of 0% and a return on equity of -3.81%, the company continues to navigate a challenging financial landscape.